Pain Medicine Doctors in Iowa Medicare Details, Address, Contact
8 Pain Medicine doctors found. Showing 1 - 8
 Jamie Ann Ruggles, RN Pain Medicine - Pain Medicine Medicare: Not Enrolled in Medicare Practice Location: 3600 30th St, Des Moines, IA 50310 Phone: 515-699-5999 Fax: 515-699-5638 |
 Mohammad S Iqbal, MD Pain Medicine - Interventional Pain Medicine Medicare: Not Enrolled in Medicare Practice Location: 330 Laurel St, Ste 1300, Des Moines, IA 50314 Phone: 515-883-2650 Fax: 515-883-2653 |
Leonard Benton, MD Pain Medicine - Interventional Pain Medicine Medicare: Medicare Enrolled Practice Location: 200 Hawkins Dr, Dept Of Anesthesia, Iowa City, IA 52242 Phone: 319-356-2633 Fax: 319-356-2940 |
Dr. Fred J Dery Jr., MD Pain Medicine - Pain Medicine Medicare: Accepting Medicare Assignments Practice Location: 2751 Northgate Dr, Iowa City, IA 52245 Phone: 319-338-3606 Fax: 319-338-0522 |
Brienna M Cameron, PA-C Pain Medicine - Pain Medicine Medicare: Accepting Medicare Assignments Practice Location: 303 East St, Lynnville, IA 50153 Phone: 641-527-2929 Fax: 641-527-2922 |
Christian Peter Ledet, MD Pain Medicine - Pain Medicine Medicare: Accepting Medicare Assignments Practice Location: 2425 Westown Pkwy Ste 100, West Des Moines, IA 50266 Phone: 515-267-1819 Fax: 515-401-1313 |
Dr. Mauricio Javier Acebey, MD Pain Medicine - Pain Medicine Medicare: Accepting Medicare Assignments Practice Location: 6001 Westown Pkwy, West Des Moines, IA 50266 Phone: 515-224-1414 Fax: 515-224-5140 |
Arpan Ghanshyam Patel, Pain Medicine - Pain Medicine Medicare: Accepting Medicare Assignments Practice Location: 5950 University Ave Ste 380, West Des Moines, IA 50266 Phone: 515-875-9902 |
News Archive
Omeros receives additional NIDA grant for clinical studies in Addiction program
Omeros Corporation today announced that the National Institute on Drug Abuse (NIDA) has provided an additional grant to fund clinical studies for the Company's Addiction program. This grant, which is for a total of approximately $3.6 million to be paid over a four-year period in equal amounts, will fund direct and indirect costs of Phase 2 clinical studies to be conducted by researchers at the New York State Psychiatric Institute.
Viewpoints: 'Accepted wisdom' about cutting entitlements disputed; Profit motive doesn't lead to good health care
It has become accepted economic wisdom that the only way to get control over America's looming budget deficits is to "reform entitlements." The accepted wisdom is wrong. ... Medicare and Medicaid costs are projected to soar. But here again, look closely and you'll see neither is really the problem. The underlying problem is the soaring cost of health care overall, combined with the aging of the boomer generation.
Calif. unveils tentative price tags for health plans on the exchange
The monthly cost for policies sold on the state-run exchange came in lower than the 30 percent rate increases some had anticipated, though some consumers will still experience sharply higher premiums. Blue Shield of California estimated that current customers would see rate increases of about 13 percent.
Researchers look at barriers related to use of contact tracing apps
As a tool for controlling the spread of COVID-19, mobile applications for contact tracing are most effective when they are widely adopted and left on indefinitely.
Biocartis closes Series 'B' equity financing round
Biocartis SA, a biotech company active in the field of personalized medicine and focused on fast, multiplexed and fully integrated molecular diagnostics based on its proprietary micro-technology and sample preparation platforms, today announced the successful closing of a Series B equity financing round. The Company raised EUR 30 million (~ USD 41.3 million) from its current shareholder base of leading life science investors and two new strategic investors from the pharmaceutical/diagnostic industry.
› Verified 7 days ago